86 related articles for article (PubMed ID: 2788095)
1. Decline in growth and antibody production of established hybridomas and transfectomas with addition of interleukin 6.
Karavodin LM; Glasebrook AL; Phelps JL
Eur J Immunol; 1989 Jul; 19(7):1351-4. PubMed ID: 2788095
[TBL] [Abstract][Full Text] [Related]
2. Prolactin is an antagonist of TGF-beta activity and promotes proliferation of murine B cell hybridomas.
Richards SM; Garman RD; Keyes L; Kavanagh B; McPherson JM
Cell Immunol; 1998 Mar; 184(2):85-91. PubMed ID: 9630834
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 1 stimulates proliferation of a nontransformed T lymphocyte line in the absence of a co-mitogen.
Lacey DL; Chappel JC; Teitelbaum SL
J Immunol; 1987 Oct; 139(8):2649-55. PubMed ID: 2958556
[TBL] [Abstract][Full Text] [Related]
4. Functional discrimination between interleukin 6 and interleukin 1.
Helle M; Boeije L; Aarden LA
Eur J Immunol; 1988 Oct; 18(10):1535-40. PubMed ID: 3263920
[TBL] [Abstract][Full Text] [Related]
5. Constitutive production of lymphokines by cloned murine B-cell lymphomas--CH12 B lymphoma produces interleukin-4.
O'Garra A; Barbis D; Harada N; Lee F; Howard M
J Mol Cell Immunol; 1989; 4(3):149-58; discussion 158-9. PubMed ID: 2788429
[TBL] [Abstract][Full Text] [Related]
6. Mast cell growth-enhancing activity (MEA) stimulates interleukin 6 production in a mouse bone marrow-derived mast cell line and a malignant subline.
Hültner L; Moeller J
Exp Hematol; 1990 Sep; 18(8):873-7. PubMed ID: 2117548
[TBL] [Abstract][Full Text] [Related]
7. Separable helper factors support B cell proliferation and maturation to Ig secretion.
Parker DC
J Immunol; 1982 Aug; 129(2):469-74. PubMed ID: 6806371
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor and interleukin 1 can act as essential growth factors in a murine plasmacytoma line.
Le J; Reis LF; Vilcek J
Lymphokine Res; 1988; 7(2):99-106. PubMed ID: 3261383
[TBL] [Abstract][Full Text] [Related]
9. Regulation of IgA differentiation in CH12LX B cells by lymphokines. IL-4 induces membrane IgM-positive CH12LX cells to express membrane IgA and IL-5 induces membrane IgA-positive CH12LX cells to secrete IgA.
Kunimoto DY; Harriman GR; Strober W
J Immunol; 1988 Aug; 141(3):713-20. PubMed ID: 2456329
[TBL] [Abstract][Full Text] [Related]
10. Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta.
Lee G; Namen AE; Gillis S; Ellingsworth LR; Kincade PW
J Immunol; 1989 Jun; 142(11):3875-83. PubMed ID: 2785567
[TBL] [Abstract][Full Text] [Related]
11. Effects of site-specific mutations on biologic activities of recombinant human IL-6.
Snouwaert JN; Kariya K; Fowlkes DM
J Immunol; 1991 Jan; 146(2):585-91. PubMed ID: 1987278
[TBL] [Abstract][Full Text] [Related]
12. IL-2 dependence of the promotion of human B cell differentiation by IL-6 (BSF-2).
Splawski JB; McAnally LM; Lipsky PE
J Immunol; 1990 Jan; 144(2):562-9. PubMed ID: 2295801
[TBL] [Abstract][Full Text] [Related]
13. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
Lasky JL; Ponzio NM; Thorbecke GJ
J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies.
Matsuda T; Hirano T; Kishimoto T
Eur J Immunol; 1988 Jun; 18(6):951-6. PubMed ID: 3260187
[TBL] [Abstract][Full Text] [Related]
15. IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells.
Punnonen J; de Vries JE
J Immunol; 1994 Feb; 152(3):1094-102. PubMed ID: 7507958
[TBL] [Abstract][Full Text] [Related]
16. Synthetic and natural factors promoting production of murine and human monoclonal antibodies.
Astaldi Ricotti GC; Negri C; Cerino A; Bestagno M; Fussi F
Ann Ist Super Sanita; 1991; 27(1):155-60. PubMed ID: 1958025
[TBL] [Abstract][Full Text] [Related]
17. Synergistic regulatory effects of interleukin 6 and interleukin 1 on the growth and differentiation of human and mouse myeloid leukemic cell lines.
Onozaki K; Akiyama Y; Okano A; Hirano T; Kishimoto T; Hashimoto T; Yoshizawa K; Taniyama T
Cancer Res; 1989 Jul; 49(13):3602-7. PubMed ID: 2786454
[TBL] [Abstract][Full Text] [Related]
18. Recombinant IL 2 but not recombinant interferon-gamma stimulates both proliferation and IgM secretion in a Ly-1+ clone of neoplastic murine B cells (BCL1).
Brooks KH; Vitetta ES
J Immunol; 1986 Nov; 137(10):3205-10. PubMed ID: 2945863
[TBL] [Abstract][Full Text] [Related]
19. Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines.
Chen Z; Colon I; Ortiz N; Callister M; Dong G; Pegram MY; Arosarena O; Strome S; Nicholson JC; Van Waes C
Cancer Res; 1998 Aug; 58(16):3668-76. PubMed ID: 9721877
[TBL] [Abstract][Full Text] [Related]
20. Autocrine growth of T cells independent of interleukin 2: identification of interleukin 4 (IL 4, BSF-1) as an autocrine growth factor for a cloned antigen-specific helper T cell.
Kupper T; Horowitz M; Lee F; Robb R; Flood PM
J Immunol; 1987 Jun; 138(12):4280-7. PubMed ID: 2953803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
